\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ over\\ site\\ of\\ acromioclavicular\\ region\\.\ \(0\)\
\-\ conservative\\ treatment\ \(40\)\
\-\ there\\ is\\ an\\ erosion\\ of\\ the\\ lateral\\ head\\ of\\ the\\ clavicle\\.\\ no\\ other\\ osseous\\ findings\\.\ \(0\)\
\-\ osteolysis\\ of\\ distal\\ clavicle\\.\ \(0\)\
\-\ differential\\ of\\ acquired\\ acroosteolysis\ \(0\)\
\-\ trauma\\/injury\ \(0\)\
\-\ systemic\\ diseases\\:\ \(0\)\
\-\ diabetes\ \(101\)\
\-\ dermatomyositis\ \(6\)\
\-\ psoriasis\ \(16\)\
\-\ ehlers\\-danlos\\ syndrome\ \(0\)\
\-\ rheumatoid\\ arthritis\ \(67\)\
\-\ reiters\ \(2\)\
\-\ scleroderma\ \(13\)\
\-\ sarcoidosis\ \(108\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ raynaud\\ disease\ \(0\)\
\-\ drug\\ therapy\\:\ \(1\)\
\-\ dilantin\ \(3\)\
\-\ pvc\\ \\(polyvinylchloride\\)\\ exposure\ \(0\)\
\-\ ergot\\ therapy\ \(0\)\
\-\ patient\\ is\\ status\\ post\\ acromioclavicular\\ trauma\\ during\\ a\\ flag\\ football\\ game\\ at\\ college\\ reunion\\.\\ although\\ the\\ initial\\ soreness\\ went\\ away\\,\\ the\\ patient\\ states\\ over\\ the\\ last\\ few\\ weeks\\ there\\ has\\ been\\ a\\ constant\\ increased\\ sensation\\/pain\\ at\\ that\\ site\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ acromioclavicular\\:\\ 0\\.2555527698305198\ \(0\)\
\-\ clavicle\\:\\ 0\\.24113934391479316\ \(0\)\
\-\ site\\:\\ 0\\.18033132380866018\ \(0\)\
\-\ polyvinylchloride\\:\\ 0\\.17878419971359094\ \(0\)\
\-\ ergot\\:\\ 0\\.17878419971359094\ \(0\)\
\-\ reunion\\:\\ 0\\.17878419971359094\ \(0\)\
\-\ acroosteolysis\\:\\ 0\\.17083784742379224\ \(0\)\
\-\ pvc\\:\\ 0\\.17083784742379224\ \(0\)\
\-\ raynaud\\:\\ 0\\.1651998207491235\ \(0\)\
\-\ reiters\\:\\ 0\\.1572534684593248\ \(0\)\
\-\ soreness\\:\\ 0\\.1572534684593248\ \(0\)\
\-\ flag\\:\\ 0\\.14930711616952605\ \(0\)\
\-\ dilantin\\:\\ 0\\.14724224854439716\ \(0\)\
\-\ college\\:\\ 0\\.1392958962545984\ \(0\)\
\-\ dermatomyositis\\:\\ 0\\.13803106282018868\ \(0\)\
\-\ psoriasis\\:\\ 0\\.13803106282018868\ \(0\)\
\-\ osteolysis\\:\\ 0\\.136842934439335\ \(0\)\
\-\ game\\:\\ 0\\.13178996960436096\ \(0\)\
\-\ trauma\\:\\ 0\\.12985228791547768\ \(0\)\
\-\ therapy\\:\\ 0\\.12846670980993302\ \(0\)\
\-\ scleroderma\\:\\ 0\\.12506889853339678\ \(0\)\
\-\ over\\:\\ 0\\.1243256314161056\ \(0\)\
\-\ constant\\:\\ 0\\.12056967195739658\ \(0\)\
\-\ football\\:\\ 0\\.11733441983326495\ \(0\)\
\-\ away\\:\\ 0\\.11609623238007157\ \(0\)\
\-\ the\\:\\ 0\\.11153555271140883\ \(0\)\
\-\ of\\:\\ 0\\.10938872341630816\ \(0\)\
\-\ went\\:\\ 0\\.10855397927612379\ \(0\)\
\-\ acquired\\:\\ 0\\.10775394508540459\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.10648911165099485\ \(0\)\
\-\ exposure\\:\\ 0\\.10624565366099373\ \(0\)\
\-\ erosion\\:\\ 0\\.10375004086879752\ \(0\)\
\-\ diseases\\:\\ 0\\.10271286149733314\ \(0\)\
\-\ diabetes\\:\\ 0\\.1021159184107359\ \(0\)\
\-\ drug\\:\\ 0\\.10172782422060142\ \(0\)\
\-\ systemic\\:\\ 0\\.09920716590913\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.09854275936119612\ \(0\)\
\-\ states\\:\\ 0\\.09821881618142013\ \(0\)\
\-\ few\\:\\ 0\\.09483397266887103\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.09469927718219737\ \(0\)\
\-\ arthritis\\:\\ 0\\.0909257949285707\ \(0\)\
\-\ last\\:\\ 0\\.0909257949285707\ \(0\)\
\-\ osseous\\:\\ 0\\.08922976501237118\ \(0\)\
\-\ there\\:\\ 0\\.08896559634919492\ \(0\)\
\-\ conservative\\:\\ 0\\.08631051070672782\ \(0\)\
\-\ at\\:\\ 0\\.08445261149073936\ \(0\)\
\-\ pain\\:\\ 0\\.08000857685045151\ \(0\)\
\-\ factoid\\:\\ 0\\.07807466842416676\ \(0\)\
\-\ status\\:\\ 0\\.07801728004885315\ \(0\)\
\-\ although\\:\\ 0\\.07610774837166923\ \(0\)\
\-\ initial\\:\\ 0\\.07499621711859333\ \(0\)\
\-\ patient\\:\\ 0\\.072722462956561\ \(0\)\
\-\ differential\\:\\ 0\\.072638834866671\ \(0\)\
\-\ during\\:\\ 0\\.07081056709098986\ \(0\)\
\-\ see\\:\\ 0\\.0695432542946734\ \(0\)\
\-\ syndrome\\:\\ 0\\.06739674319687054\ \(0\)\
\-\ weeks\\:\\ 0\\.0670008081920023\ \(0\)\
\-\ region\\:\\ 0\\.0668705876719346\ \(0\)\
\-\ head\\:\\ 0\\.0666768650122263\ \(0\)\
\-\ been\\:\\ 0\\.06513290821643354\ \(0\)\
\-\ distal\\:\\ 0\\.06495554848863468\ \(0\)\
\-\ is\\:\\ 0\\.061231523054399994\ \(0\)\
\-\ post\\:\\ 0\\.060831110742440894\ \(0\)\
\-\ increased\\:\\ 0\\.06045330403209795\ \(0\)\
\-\ other\\:\\ 0\\.058056826932240964\ \(0\)\
\-\ lateral\\:\\ 0\\.055481296852663786\ \(0\)\
\-\ findings\\:\\ 0\\.05517521072757708\ \(0\)\
\-\ treatment\\:\\ 0\\.05325378832593713\ \(0\)\
\-\ has\\:\\ 0\\.05106460056198801\ \(0\)\
\-\ that\\:\\ 0\\.04851474440229455\ \(0\)\
\-\ disease\\:\\ 0\\.0469274793871537\ \(0\)\
\-\ an\\:\\ 0\\.04274995068689854\ \(0\)\
\-\ no\\:\\ 0\\.03635439214260977\ \(0\)\
